Trial comparisons

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=56

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT02451670-sae",
        "title": "Prioritized Clinical Decision Support vs Usual Care: serious adverse events",
        "summary": "722 of 4550 against 763 of 4387; risk difference -1.5 points, 95% interval -3.1 to 0.0; NCT02451670, Reducing Cardiovascular Risk in Adults With Serious Mental Illness",
        "record": "/library/comparisons/NCT02451670-sae",
        "nct_id": "NCT02451670",
        "kind": "serious-adverse-events",
        "participants": 8937,
        "risk_difference": {
          "value": -0.015241635501494183,
          "lower": -0.030698952429049672,
          "upper": 0.000197191903036905
        },
        "group_1": "722 of 4,550",
        "group_2": "763 of 4,387",
        "difference": "-1.5 points",
        "interval": "-3.1 to 0.0",
        "trial_title": "Reducing Cardiovascular Risk in Adults With Serious Mental Illness"
      },
      {
        "id": "NCT01601704-3292f305",
        "title": "NB32 vs Placebo: Percentage of Participants With a Confirmed Occurrence of Myocardial Infarction (Nonfatal or Fatal)",
        "summary": "55 of 4455 against 57 of 4450; risk difference -0.0 points, 95% interval -0.5 to 0.4; NCT01601704, Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)",
        "record": "/library/comparisons/NCT01601704-3292f305",
        "nct_id": "NCT01601704",
        "kind": "outcome",
        "participants": 8905,
        "risk_difference": {
          "value": -0.0004633097516992656,
          "lower": -0.005171709080444309,
          "upper": 0.004234116650856166
        },
        "group_1": "55 of 4,455",
        "group_2": "57 of 4,450",
        "difference": "-0.0 points",
        "interval": "-0.5 to 0.4",
        "trial_title": "Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=57",
  "request_id": "ORnCs0idxII2eS2-"
}